Vogenx

VOGX · NASDAQ

$17.45−$1.63 (−8.54%)TodayMarket closed ·
Prev close $19.08

Latest news

  • Press releaseACCESS Newswire

    Vogenx Initiates Phase 2b EMERGE Study of Mizagliflozin for Post-Bariatric Hypoglycemia

  • Press releaseACCESS Newswire

    Vogenx Appoints Board Member Richard Gorman as Chief Commercial Officer

  • Press releaseACCESS Newswire

    Vogenx Appoints Ken Toombs to Board of Directors

  • NewsAvi Kapoor

    Wealthfront, Orchestra Biomed, AeroVironment And Other Big Stocks Moving Higher On Thursday

  • Press releasePRNewswire

    Jones Served as Sole Book-Running Manager for Vogenx's $81.3 Million Initial Public Offering

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.